GBP2 and neurodegenerative disease: From this perspective, our study demonstrates that the downregulation of GBP2 can minimize neuronal damage caused by the induction of anti-inflammatory functions in activated microglia, providing evidence supporting GBP2 as a potential candidate molecule for alleviating neurodegenerative diseases.